廣州鴻程生物有限公司一家專注于生命科學的科技企業(yè)，由在國內(nèi)科研試劑領域有著豐富從業(yè)經(jīng)驗的技術團隊和管理團隊組建而成，專營進口生物試劑，科學儀器，實驗消耗品等。公司將不斷把上優(yōu)質(zhì)的產(chǎn)品引入國內(nèi)市場，滿足客戶的需求，公司也將緊跟生命科學的發(fā)展，為廣大科研工作者探索生命科學的奧秘奉獻綿薄之力.專門從事以抗*BeckmanA63881的磁珠現(xiàn)貨，moltox11-101.5等現(xiàn)貨，transgenomic706020/706025現(xiàn)貨
NA12878 Coriell InstituteDNA和細胞廣州鴻程代理
Coriell Institute作為已被國際認可的quanwei機構，致力于為個性化醫(yī)療和干細胞生物學快速發(fā)展做出貢獻。其中，Biobank的人類基因組DNA標準品，已廣泛應用被國內(nèi)各大zhiming基因公司及科研單位所信賴。其中，NA12878在國內(nèi)也已成為基因組測序行業(yè)的標準。
以NA12878為例，展示如下：
NA12878DNAfromLCL
Description:
CEPH/UTAHPEDIGREE1463INTERNATIONALHAPMAPPROJECT-CEPH(PLATEI)[UTAHRESIDENTSWITHANCESTRYFROMNORTHERNANDWESTERNEUROPE]
CYTOCHROMEP450,SUBFAMILYIIC,POLYPEPTIDE19;CYP2C19
INTERNATIONALHAPMAPPROJECT-CEPH[UTAHRESIDENTSWITHANCESTRYFROMNORTHERNANDWESTERNEUROPE]
NACUSTOMSERVICEPLATE01
Affected:NoData
Gender:Female
Age:NoData
Repository:NIGMSHumanGeneticCellRepository
Subcollection:CEPH
RepositoryLinkageFamilies
Pharmacogenetics
PIGIConsentedSample
Quantity:50µg
Quantitation:MethodPleaseseeourFAQ
BiopsySource:Peripheralvein
CellType:B-Lymphocyte
TissueType:Blood
Transformant:Epstein-BarrVirus
Race:Caucasian
Ethnicity:UTAH/MORMON
CountryofOrigin:USA
FamilyMember:2
RelationtoProband:mother
Confirmation:Clinicalsummary/Casehistory
ISCN:46,XX[23].arr[hg19]9p13.1(38,787,480-40,911,212)x3
Species:Homosapiens
CommonName:Human
Remarks:
Mother;donorsubjecthasasinglebp(G-to-A)transitionatnucleotide681inexon5oftheCYP2C19gene(CYP2C19*2)whichcreatesanaberrantsplicesite.ThechangealteredthereadingframeofthemRNAstartingwithaminoacid215andproducedaprematurestopcodon20aminoacidsdownstream,resultinginatruncated,nonfunctionalprotein.Becauseoftheaberrantsplicesite,a40-bpdeletionoccurredatthebeginningofexon5(frombp643tobp682),resultingindeletionofaminoacids215to227.Thetruncatedproteinhad234aminoacidsandwouldbecatalyticallyinactivebecauseitlackedtheheme-bindingregion.
